{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-04-01",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "status": "Terminated",
      "city": "Bridgewater",
      "state": "NJ",
      "country": "United States",
      "classification": "Class III",
      "openfda": {},
      "product_type": "Drugs",
      "event_id": "69359",
      "recalling_firm": "Valeant Pharmaceuticals International",
      "address_1": "400 Somerset Corporate Blvd",
      "address_2": "N/A",
      "postal_code": "08807-2867",
      "voluntary_mandated": "Voluntary: Firm initiated",
      "initial_firm_notification": "Letter",
      "distribution_pattern": "Nationwide and Puerto Rico",
      "recall_number": "D-0025-2015",
      "product_description": "Hydrocortisone Butyrate Cream 0.1%, Net Wt. 15 gm tubes, Rx only, Manufactured for:  Rouses Point Pharmaceuticals, LLC Cranford, NJ 07016 By:  Ferndale Laboratories, Inc. Ferndale, MI  48220 --- NDC 43478-270-15",
      "product_quantity": "34,218 tubes",
      "reason_for_recall": "Subpotent Drug; for the active, HCB, and preservatives, Propylparaben and Butylparaben at the 18 month stability test point",
      "recall_initiation_date": "20141002",
      "center_classification_date": "20141016",
      "termination_date": "20150403",
      "report_date": "20141022",
      "code_info": "Lot numbers 13052C, exp 03/2015 and 13156A, exp 08/2015, NDC 43478-270-15"
    }
  ]
}